IRVINE, Calif., Jan. 6, 2016 /PRNewswire/ -- Edwards Lifesciences
Corporation (NYSE: EW), the global leader in patient-focused
innovations for structural heart disease and critical care
monitoring, is scheduled to present at the J.P. Morgan Healthcare
Conference at the Westin St. Francis in San Francisco on Monday, January 11, 2016.
Michael A. Mussallem, chairman
and chief executive officer, is scheduled to speak to conference
attendees at 10:30 a.m. PT. A
live webcast of the presentation will be available to all
interested parties on the Edwards Lifesciences investor relations
website at http://ir.edwards.com/events.cfm. An archived version of
the webcast will be available later that day on the Edwards
investor relations website in the News and Events section and via
the Edwards Lifesciences Investor Relations App for mobile
devices.
About Edwards Lifesciences
Edwards Lifesciences, based
in Irvine, Calif., is the global
leader in patient-focused medical innovations for structural heart
disease, as well as critical care and surgical monitoring.
Driven by a passion to help patients, the company collaborates with
the world's leading clinicians and researchers to address unmet
healthcare needs, working to improve patient outcomes and enhance
lives. For more information, visit www.Edwards.com and follow us on
Twitter at @EdwardsLifeSci.
Edwards, Edwards Lifesciences, and the stylized E logo are
trademarks of Edwards Lifesciences Corporation.
Logo - http://photos.prnewswire.com/prnh/20140714/126903
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/edwards-lifesciences-to-present-at-the-34th-annual-jp-morgan-healthcare-conference-300199839.html
SOURCE Edwards Lifesciences Corporation